Leigh Turner

1

Article

1

Comment
  • Associate Professor, University of Minnesota Center for Bioethics, School of Public Health, & College of Pharmacy, University of Minnesota
Laboratories around the world are working round the clock to find treatments or a vaccine for COVID-19. Getty Images / Kena Betancur

Could pressure for COVID‑19 drugs lead the FDA to lower its standards?

Leigh Turner, University of Minnesota

The FDA has sped up its approval process for coronavirus treatments, creating a new division to expedite the regulatory process. But is safety being sidelined for speed?

Contact Leigh for

  • General
  • Media request
  • Speaking request
  • Research collaboration
  • Research supervision